A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency
JH Chesebro, IP Clements, V Fuster, LR Elveback, HC Smith, WT Bardsley, RL Frye, DR Holmes, RE Vlietstra, JR Pluth, RB Wallace, FJ Puga, TA Orszulak, JM Piehler, HV Schaff, and GK Danielson
To prevent occlusion of aortocoronary-artery-bypass grafts, we conducted a prospective, randomized-double-blind trial comparing dipyridamole (instituted two days before operation) plus aspirin (added seven hours after operation) with placebo in 407 patients. Vein-graft angiography was performed in 360 patients (88 per cent) within six months of operation (median, eight days). Within one month of operation, 3 per cent of vein-graft distal anastomoses (10 of 351) were occluded in the treated patients, and 10 per cent (38 of 362) in the placebo group; the proportion of patients with one or more distal anastomoses occluded was 8 per cent (10 of 130) in the treated group and 21 per cent (27 of 130) in th placebo group. This benefit in graft patency persisted in each of over 50 subgroups. Early postoperative bleeding was similar in the two groups. In this trial dipyridamole and aspirin were effective in preventing graft occlusion early after operation.
This article has been cited by other articles:
Dunning, J., Waller, J. R.L., Smith, B., Pitts, S., Kendall, S. W.H., Khan, K.
(2008). Coronary Artery Bypass Grafting is Associated With Excellent Long-Term Survival and Quality of Life: A Prospective Cohort Study.. Ann. Thorac. Surg.
85: 1988-1993
[Abstract][Full Text]
Sun, J. C.J., Whitlock, R., Cheng, J., Eikelboom, J. W., Thabane, L., Crowther, M. A., Teoh, K. H.T.
(2008). The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. Eur Heart J
29: 1057-1071
[Abstract][Full Text]
Desai, N. D., Miwa, S., Kodama, D., Koyama, T., Cohen, G., Pelletier, M. P., Cohen, E. A., Christakis, G. T., Goldman, B. S., Fremes, S. E.
(2006). A randomized comparison of intraoperative indocyanine green angiography and transit-time flow measurement to detect technical errors in coronary bypass grafts. J. Thorac. Cardiovasc. Surg.
132: 585-594
[Abstract][Full Text]
Vincentelli, A., Jude, B., Belisle, S.
(2006). Antithrombotic therapy in cardiac surgery: [Traitement antithrombotique en chirurgie cardiaque].. Canadian J. Anesthesia
53: S89-S102
[Abstract][Full Text]
Gurbuz, A. T., Zia, A. A., Vuran, A. C., Cui, H., Aytac, A.
(2006). Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study. Eur. J. Cardiothorac. Surg.
29: 190-195
[Abstract][Full Text]
Bybee, K. A., Powell, B. D., Valeti, U., Rosales, A. G., Kopecky, S. L., Mullany, C., Wright, R. S.
(2005). Preoperative Aspirin Therapy Is Associated With Improved Postoperative Outcomes in Patients Undergoing Coronary Artery Bypass Grafting. Circulation
112: I-286-I-292
[Abstract][Full Text]
Sun, J. C.J., Crowther, M. A., Warkentin, T. E., Lamy, A., Teoh, K. H.T.
(2005). Should Aspirin Be Discontinued Before Coronary Artery Bypass Surgery?. Circulation
112: e85-e90
[Full Text]
Epstein, A. E., Alexander, J. C., Gutterman, D. D., Maisel, W., Wharton, J. M.
(2005). Anticoagulation: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery. Chest
128: 24S-27S
[Abstract][Full Text]
Ferguson, T. B. Jr
(2004). Preoperative calcium-channel blockade in cardiac surgery: the good, the bad, the issues. J. Thorac. Cardiovasc. Surg.
127: 622-624
[Full Text]
Tanner, F. C., Largiader, T., Greutert, H., Yang, Z., Luscher, T. F.
(2004). Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein. J. Thorac. Cardiovasc. Surg.
127: 20-26
[Abstract][Full Text]
Lim, E., Ali, Z., Ali, A., Routledge, T., Edmonds, L., Altman, D. G, Large, S.
(2003). Indirect comparison meta-analysis of aspirin therapy after coronary surgery. BMJ
327: 1309-
[Abstract][Full Text]
Srinivasan, A. K., Grayson, A. D., Pullan, D. M., Fabri, B. M., Dihmis, W. C.
(2003). Effect of preoperative aspirin use in off-pump coronary artery bypass operations. Ann. Thorac. Surg.
76: 41-45
[Abstract][Full Text]
Chesebro, J. H., Fuster, V., Pugo, F. J., Karzai, W., Priebe, H.-J., Mangano, D. T.
(2003). Aspirin and Mortality from Coronary Bypass Surgery. NEJM
348: 1057-1059
[Full Text]
Chiu-Pinheiro, C. K., O'Brien, T., Katusic, Z. S., Bonilla, L. F., Hamner, C. E., Schaff, H. V.
(2002). Gene transfer to coronary artery bypass conduits. Ann. Thorac. Surg.
74: 1161-1166
[Abstract][Full Text]
Hongo, R. H., Ley, J., Dick, S. E., Yee, R. R.
(2002). The effect of clopidogrel incombination with aspirin whengiven before coronary artery bypass grafting. J Am Coll Cardiol
40: 231-237
[Abstract][Full Text]
Holmvang, L., Jurlander, B., Rasmussen, C., Thiis, J. J., Grande, P., Clemmensen, P.
(2002). Use of Biochemical Markers of Infarction for Diagnosing Perioperative Myocardial Infarction and Early Graft Occlusion After Coronary Artery Bypass Surgery. Chest
121: 103-111
[Abstract][Full Text]
Huynh, T., Theroux, P., Bogaty, P., Nasmith, J., Solymoss, S.
(2001). Aspirin, Warfarin, or the Combination for Secondary Prevention of Coronary Events in Patients With Acute Coronary Syndromes and Prior Coronary Artery Bypass Surgery. Circulation
103: 3069-3074
[Abstract][Full Text]
Domanski, M. J., Borkowf, C. B., Campeau, L., Knatterud, G. L., White, C., Hoogwerf, B., Rosenberg, Y., Geller, N. L., the Post-CABG Trial Investigators,
(2000). Prognostic factors for atherosclerosis progression in saphenous vein grafts: The postcoronary artery bypass graft (post-CABG) trial. J Am Coll Cardiol
36: 1877-1883
[Abstract][Full Text]
Vodovotz, Y., Waksman, R., Kim, W.-H., Bhargava, B., Chan, R. C., Leon, M.
(1999). Effects of Intracoronary Radiation on Thrombosis After Balloon Overstretch Injury in the Porcine Model. Circulation
100: 2527-2533
[Abstract][Full Text]
Corbineau, H., Lebreton, H., Langanay, T., Logeais, Y., Leguerrier, A.
(1999). Prospective evaluation of coronary arteries: influence on operative risk in coronary artery surgery. Eur. J. Cardiothorac. Surg.
16: 429-434
[Abstract][Full Text]
Loop, F. D.
(1998). Coronary artery surgery: the end of the beginning. Eur. J. Cardiothorac. Surg.
14: 554-571
[Abstract][Full Text]
Salas, E, Langford, E J, Marrinan, M T, Martin, J F, Moncada, S, de Belder, A J
(1998). S-Nitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo. Heart
80: 146-150
[Abstract][Full Text]
Cohen, G., Ivanov, J., Weisel, R. D., Rao, V., Mohabeer, M. K., Mickle, D. A. G.
(1998). Aprotinin and Dipyridamole for the Safe Reduction of Postoperative Blood Loss. Ann. Thorac. Surg.
65: 674-683
[Abstract][Full Text]
Becquemin, J.-P., The Etude de la Ticlopidineapres Pontage Femoro-Po,
(1997). Effect of Ticlopidine on the Long-Term Patency of Saphenous-Vein Bypass Grafts in the Legs. NEJM
337: 1726-1731
[Abstract][Full Text]
Bidstrup, B. P.
(1997). Coronary Artery Bypass Graft Patency. SEMIN CARDIOTHORAC VASC ANESTH
1: 282-287
[Abstract]
O'Connor, N. J., Morton, J. R., Birkmeyer, J. D., Olmstead, E. M., O'Connor, G. T.
(1996). Effect of Coronary Artery Diameter in Patients Undergoing Coronary Bypass Surgery. Circulation
93: 652-655
[Abstract][Full Text]
Mickleborough, L. L., Takagi, Y., Maruyama, H., Sun, Z., Mohamed, S.
(1995). Is Sex a Factor in Determining Operative Risk for Aortocoronary Bypass Graft Surgery?. Circulation
92: 80-84
[Abstract][Full Text]
Utley, J. R., Wilde, E. F., Leyland, S. A., Morgan, M. S., Johnson, H. D.
(1995). Intraoperative Blood Transfusion Is a Major Risk Factor for Coronary Artery Bypass Grafting in Women. Ann. Thorac. Surg.
60: 570-574
[Abstract][Full Text]
Dietl, C. A., Benoit, C. H.
(1995). Radial Artery Graft for Coronary Revascularization: Technical Considerations. Ann. Thorac. Surg.
60: 102-109
[Abstract][Full Text]
Rajah, S. M., Nair, U., Rees, M., Saunders, N., Walker, D., Williams, G., Critchley, A., Beton, D., Campbell, C., Lawson, R. A., Rahman, A., Nair, K. K., Dyet, J., Kushwaha, S., Rees, A., Powell, J. D., Drake, J.
(1994). Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg.
107: 1146-1153
[Abstract][Full Text]
(1994). Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ
308: 159-168
[Abstract][Full Text]
Antiplatelet Trialists,
(1994). Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ
308: 81-106
[Abstract][Full Text]
Weisel, R. D
(1993). Agents that modify haemostasis after cardiopulmonary bypass. Perfusion
8: 6-12
[Abstract]
Clagett, G. P.
(1990). Antithrombotic Drugs and Vascular Surgery. PERSPECT VASC SURG ENDOVASC THER
3: 79-102
Bidstrup, B. P, Royston, D., McGuinness, C., Sapsford, R. N
(1990). Aprotinin in aspirin-pretreated patients. Perfusion
5: 77-81
[Abstract]
Bidstrup, B. P
(1988). Review article : Blood conservation in cardiac surgery: can drugs help?. Perfusion
3: 171-177
Imperial, E. S
(1987). Approach to cardiac rehabilitation. Clin Rehabil
1: 203-210
[Abstract]
Goldman, M., McCollum, C.
(1984). A Prospective Randomized Study to Examine the Effect of Aspirin Plus Dipyridamole on the Patency of Prosthetic Femoro-Popliteal Grafts. VASC ENDOVASCULAR SURG
18: 217-221
[Abstract]